We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Optibiotix Health Plc | LSE:OPTI | London | Ordinary Share | GB00BP0RTP38 | ORD 2P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.00 | 17.50 | 18.50 | 18.00 | 18.00 | 18.00 | 6,395 | 07:47:14 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Noncomml Resh Organizations | 457k | 2.59M | 0.0284 | 6.34 | 16.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
08/11/2017 10:01 | Parob...or pongs! | rayrac | |
08/11/2017 10:00 | Its a discussion post jujudi,its not meant to be your self congratulatory,jump up and down happy clapper post. I actually missed an important bit..the price if adding it to say daily breakfast cereal means a jump in price and I don't know then persuading the consumer becomes more difficult. these are the questions the big investors are told to wonder about when they take advice and that is why the share price is not rocketing...its not due to conspiratorial secret price manipulation and those pesky market makers. persuade the market that consumers will go for it and up goes the price...simple as that! | chrisg11 | |
08/11/2017 09:52 | A mostly negative slant Followed by “Overall very promising so far” Funny | judijudi | |
08/11/2017 09:46 | m4tinu Thanks for that but yes I know that. We have flogged this to death even I agree. Hopefully I will eventually get hold of the published paper. i was only vaguely interested in the peer review itself to see if it was open i.e. comments published,who were the reviewers?,was the review single blind,double blind or did everyone know of each other i.e. not blind at all. Its a small,simple enough trial so I am keen to have a look at a published version,let me know if you get one. Comment on slimbiome..Very good news today because...... The failings of the micro biome concept in a 'slimming shake' is that due to the short timescale of taking,say 4 weeks,any gut metabolic effect due to the prebiotic is short lived therefore not super helpful. Introducing everyday products will allow long term beneficial interference with the gut bacteria hopefully...of course the prebiotic will need to generate enough bacteria to produce a long term metabolic effect and not have the failings of most probiotics i.e. the levels are too low. Optibiotix has to get over to the market and indeed the consumer that this is not another me too..Its got to be significantly better than a low carb shake with an added bulking agent as its significantly more expensive indeed its very expensive. Its quite easy to get 100 per cent weight loss rates[in the group who follow the instructions] as any low carb shake will do this. The magic will be long term results by the daily taking of slimbiome if it achieves the weight loss and metabolic goals. One of my concerns over the present product is that the overall fibre content may be too high as a gut deprived of its usual amount of food is very sensitive to fibre thus I would be interested in failure rates due to gastrointestinal symptoms e.g. diarrhoea Overall..very promising so far | chrisg11 | |
08/11/2017 09:44 | Opti-Inside | loungeact | |
08/11/2017 09:38 | nasdaq quote? lol you need to show profits etc mate tuttut | fathenry | |
08/11/2017 09:35 | Owen, as far as I know, no one says that.. I was just making a comment on timing. :-) | 1bokke | |
08/11/2017 09:26 | Who says atheists can’t drool over Christmas presents 1bokke? | owenmo | |
08/11/2017 09:25 | As I mentioned the other day, we tend to rise more on the day after an RNS. Can't be long now until this pings. | parob | |
08/11/2017 09:22 | I am as surprised as everyone at the lack of buying interest so far today, but even more astonished at the selling by the impatient, or those sensing immediate opportunities.More patience now required by the LTH, maybe it will liven up later in the day when there is some media coverage? I haven't yet given up hope of a close at 74p. | tightfist | |
08/11/2017 09:08 | Agree with Judi, I don't get the selling this morning either. I know that people have their own reasons for doing so but given where we are and with this mornings release, selling now just seems seems like coming down the stairs on Xmas morning seeing all the presents under the tree and declaring yourself an atheist. Timing is just all wrong. | 1bokke | |
08/11/2017 09:00 | This is perfect for me as I had to sell some to move...I never thought that with the recent news that I could buy these back at these levels. The aim market can be a stupid place. | bobdown2 | |
08/11/2017 09:00 | Indeed! You get the sense that the company is bursting to tell us more but can't for obvious reasons. Although nothing new, the "US partners" and "large retailers" comments are hugely exciting. | colinzeal | |
08/11/2017 08:59 | Get us on Nasdaq where the story will be much more appreciated by a much wider audience Aim Cesspit isn’t for Opti imho | judijudi | |
08/11/2017 08:56 | If they have any sense at all...they’ll give this a very wide miss, at least until there’s a sign of income/profit! | rayrac | |
08/11/2017 08:52 | These new products are most likely from developments coming from the sugar division. The oligofructose prebiotic fibre which is currently in slimbiome can be changed to specific sugars that impact on other areas of health. We probably hear a fraction of what's actually going on behind the scenes. | riskybusiness1 | |
08/11/2017 08:48 | Early in the day so no worries on the share price reaction. I do think Jo public is being far more careful with his cash atm. This means some will wait until the revenues appear on the balance sheet no doubt. | rafboy | |
08/11/2017 08:29 | But...but Chris has a lot of expertise, he would know this.. | loungeact | |
08/11/2017 08:24 | Chris - from this article, it would appear a peer review is a process of scrutiny not a publication: | m4rtinu | |
08/11/2017 08:20 | I cannot understand anybody selling at this pivotal time in our history What a perfect time to be buying, not selling | judijudi | |
08/11/2017 08:16 | Unfortunately at present, investors, the market just isnt listening.Volume and interest has been very low despite some excellent news. | john henry | |
08/11/2017 08:16 | Bought some....5.000 I am very suprised at the lack of buying. I expect some want a diagram to go with the r.n.s. | bobdown2 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions